AllPennyStocks.com Why Is CAPR Stock Rising Today? Piper Sandler Says Risk-Reward Favors Owning Stock Into FDA Decision
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Why Is CAPR Stock Rising Today? Piper Sandler Says Risk-Reward Favors Owning Stock Into FDA Decision

Piper Sandler upgraded Capricor to ‘Overweight’ from ‘Neutral’ and sharply raised the price target to $25, a roughly 150% upside potential from current levels.

Other Penny Stock Movers

Nasdaq Biotech Surges 46% on Photonic Supercomputing Acquisition
The First Ounces Out of a New Mine Are Almost Always Spoken For
Copper's Real Constraint Isn't Demand. It's Ground
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top